BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15790304)

  • 1. Betulinic acid and its derivatives: a review on their biological properties.
    Yogeeswari P; Sriram D
    Curr Med Chem; 2005; 12(6):657-66. PubMed ID: 15790304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the study of structural modifications and biological activities of betulinic acids].
    Lan P; Zhang DM; Chen WM; Ye WC
    Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
    Cichewicz RH; Kouzi SA
    Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.
    Kumar V; Rani N; Aggarwal P; Sanna VK; Singh AT; Jaggi M; Joshi N; Sharma PK; Irchhaiya R; Burman AC
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5058-62. PubMed ID: 18752941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.
    Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH
    Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives.
    Kashiwada Y; Chiyo J; Ikeshiro Y; Nagao T; Okabe H; Cosentino LM; Fowke K; Morris-Natschke SL; Lee KH
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1387-90. PubMed ID: 10993248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxicity of bidesmosidic betulin and betulinic acid saponins.
    Gauthier C; Legault J; Lavoie S; Rondeau S; Tremblay S; Pichette A
    J Nat Prod; 2009 Jan; 72(1):72-81. PubMed ID: 19115839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
    Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L
    J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and Anti-HIV Activity of Betulinic Acid Analogues.
    Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X
    Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betulinic acid derivatives as anticancer agents: structure activity relationship.
    Mukherjee R; Kumar V; Srivastava SK; Agarwal SK; Burman AC
    Anticancer Agents Med Chem; 2006 May; 6(3):271-9. PubMed ID: 16712455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.
    Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH
    J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives.
    Huang L; Ho P; Lee KH; Chen CH
    Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide: Synthetic Methods and Biological Activities.
    Hao M; Lv M; Xu H
    Mini Rev Med Chem; 2020; 20(16):1633-1652. PubMed ID: 32348215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.
    Huang L; Yuan X; Aiken C; Chen CH
    Antimicrob Agents Chemother; 2004 Feb; 48(2):663-5. PubMed ID: 14742233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of the ubiquitous natural product betulin.
    Alakurtti S; Mäkelä T; Koskimies S; Yli-Kauhaluoma J
    Eur J Pharm Sci; 2006 Sep; 29(1):1-13. PubMed ID: 16716572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation.
    Chen Y; Sit SY; Chen J; Swidorski JJ; Liu Z; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Lin Z; Li Z; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker ID; Meanwell NA; Regueiro-Ren A
    Bioorg Med Chem Lett; 2018 May; 28(9):1550-1557. PubMed ID: 29631960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents.
    Baglin I; Mitaine-Offer AC; Nour M; Tan K; Cavé C; Lacaille-Dubois MA
    Mini Rev Med Chem; 2003 Sep; 3(6):525-39. PubMed ID: 12871156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of bioactive 28-hydroxy-3-oxolup-20(29)-en-30-al with antileukemic activity.
    Ghosh P; Mandal A; Ghosh J; Pal C; Nanda AK
    J Asian Nat Prod Res; 2012; 14(2):141-53. PubMed ID: 22166062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants.
    Dang Z; Qian K; Ho P; Zhu L; Lee KH; Huang L; Chen CH
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5190-4. PubMed ID: 22818973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the divergent activities of betulinic acid via neoglycosylation.
    Goff RD; Thorson JS
    Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.